Workhorse W56 Extended Wheelbase Model Achieves FMVSS and HVIP Certification, Now in Full Production for Q4 2024 Deliveries

The W56 208-inch extended wheelbase model has completed the certification process for FMVSS and received HVIP certification for safety and environmental compliance. Full production of the W56 is underway at Workhorse’s Union City, Indiana facility, with deliveries expected in Q4 2024. With over 100 enhancements to the original step van model, the extended wheelbase W56 […]

scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024

BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that it will host a KOL webinar focused on a nephrologist’s perspective on the

Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler

BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced the appointment of Dr. Amy Wechsler to its Board of Directors. Dr. Wechsler brings a unique combination of expertise and a proven track record of leadership in

Circana Reveals Value-Based Deals, Not Just Price, Drive 54 Billion Global Foodservice Visits

Chicago, IL, Oct. 15, 2024 (GLOBE NEWSWIRE) — The foodservice industry is experiencing a fundamental shift in consumer behavior, with value emerging as the primary driver behind purchasing decisions worldwide, accounting for 54 billion visits annually, according to the latest Circana(TM) research. As inflation continues to challenge household budgets, consumers are looking beyond the lowest

ETC Announces Fiscal 2025 Second Quarter Results

SOUTHAMPTON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) — Environmental Tectonics Corporation (OTC Pink: ETCC) (“ETC” or the “Company”) today reported its financial results for the thirteen week period ended August 23, 2024 (the “2025 fiscal second quarter”) and the twenty-six week period ended August 23, 2024. Robert L. Laurent, Jr., ETC’s Chief Executive Officer and

CVR Energy to Release Third Quarter 2024 Earnings Results

SUGAR LAND, Texas, Oct. 15, 2024 (GLOBE NEWSWIRE) — CVR Energy, Inc. (NYSE: CVI) plans to release its third quarter 2024 earnings results on Monday, Oct. 28, after the close of trading on the New York Stock Exchange. The Company also will host a teleconference call on Tuesday, Oct. 29, at 1 p.m. Eastern to

CVR Partners to Release Third Quarter 2024 Earnings Results

SUGAR LAND, Texas, Oct. 15, 2024 (GLOBE NEWSWIRE) — CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (UAN) solution fertilizer products, plans to release its third quarter 2024 earnings results on Monday, Oct. 28, after the close of trading on the New York Stock Exchange. The Partnership also will host

Hudson Technologies to Host Conference Call to Discuss Third Quarter 2024 Results

WOODCLIFF LAKE, N.J., Oct. 15, 2024 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) will host a conference call and webcast on Monday, November 4, 2024 at 5:00 p.m. Eastern Time to discuss the Company’s third quarter 2024 results. Advance registration for the call is required. Please visit this link by Monday, November 4, 2024

Knight Therapeutics Announces Approval of Minjuvi(R) (tafasitamab) in Mexico

MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V. has obtained regulatory approval by COFEPRIS, the Mexican health regulatory agency, for Minjuvi(R) (tafasitamab) in combination with lenalidomide followed by Minjuvi(R) monotherapy for

Scroll to Top